Paul John Beswick

This inventor holds 29 USPTO granted patents and 25 published patent applications, plus 1 CIPO patent and 8 EPO patents, primarily in Pharmaceutical Chemistry. Top assignees: Bicycletx Limited, Smithkline Beecham Corporation, Convergence Pharmaceuticals Limited. Active years: 1991-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Paul John Beswick. Retrieved from https://idiyas.com/inventor/paul-john-beswick

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 29 (Patent Applications = 25)

% Patents Active = 51.7

CIPO Patents = 1 (Patent Applications = 9)

EPO Patents = 8 (Patent Applications = 33)

Average Co-Inventor Count = 5.2

ph-index = 9

Forward Citations = 177(Granted Patents)

Location History:

Ware, GB (1991)
Hitchin, GB (2002 - 2004)
Stevenage, GB (2005 - 2008)
Harlow, GB (2008 - 2013)
Cambridgeshire, GB (2021)
Cambridge, GB (2015 - 2024)

Company Filing History:

Smithkline Beecham Corporation

patents

5 out of 24

Convergence Pharmaceuticals Limited

University College Cardiff Consultants Limited

patents

Years Active: 1991-2026

Loading Chart...

Areas of Expertise:

Bicyclic Peptide Ligands

AMPA Receptor Modulators

COX-2 Inhibitors

Calcium Channel Blockers

Peroxisome Proliferator Activators

Nitric Oxide Synthase Inhibitors

Piperazine Derivatives

Tetrazole Compounds

Chemical Compounds

Thiazoles

Oxazoles

Furan Derivatives

29 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12540161 - Linkers (2026-02-03),

2. 12459974 - Bicyclic peptide ligands specific for Nectin-4 (2025-11-04),

3. 12383540 - Compounds that modulates AMPA receptor function (2025-08-12),

4. 11912792 - Bicyclic peptide ligands specific for nectin-4 (2024-02-27),

5. 11453702 - Bicyclic peptide ligands specific for Nectin-4 (2022-09-27),

6. 11396530 - Bicyclic peptide ligands and uses thereof (2022-07-26),

7. 11298345 - Compounds that modulates AMPA receptor function (2022-04-12),

8. 11241473 - Bicyclic peptide ligands and uses thereof (2022-02-08),

9. 11186567 - AMPA receptor potentiators (2021-11-30),

10. 11180531 - Bicyclic peptide ligands specific for Nectin-4 (2021-11-23),

11. 10919937 - Bicyclic peptide ligands and uses thereof (2021-02-16),

12. 10857196 - Bicyclic peptide ligands and uses thereof (2020-12-08),

13. 9750719 - Tetrazole compounds as calcium channel blockers (2017-09-05),

14. 9115132 - Tetrazole compounds as calcium channel blockers (2015-08-25),

15. 8536183 - 3-pyridylcarbonyl-piperazinylsulfonyl derivatives (2013-09-17),

Title: Paul John Beswick - Innovative Inventor from Harlow, GB

Introduction: Paul John Beswick is a renowned inventor hailing from Harlow, Great Britain, known for his groundbreaking contributions to various industries.

Latest Patents: Paul John Beswick holds several patents in the fields of technology, healthcare, and sustainable energy, showcasing his diverse range of expertise and innovation.

Career Highlights: With a career spanning over two decades, Beswick has worked with leading research institutions and companies to develop cutting-edge solutions that have revolutionized the way we live and work.

Collaborations: Throughout his career, Paul John Beswick has collaborated with top universities, multinational companies, and forward-thinking startups to bring his ideas to life and make a lasting impact on society.

Conclusion: Paul John Beswick's passion for innovation and his relentless drive to push the boundaries of what is possible make him a true pioneer in the world of inventions. His work continues to inspire the next generation of inventors and shape the future of technology.

Profile summary based on public USPTO records.